secwatch.observer — SEC 8-K summary
======================================

Issuer:     REVELATION BIOSCIENCES, INC. (REVB)
CIK:        0001810560
Form:       8-K
Filed at:   2023-08-11T23:59:59+00:00
Accession:  0000950170-23-041840
Event type: regulatory
Sentiment:  negative
Materiality: 0.70
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Revelation Biosciences receives Nasdaq bid price deficiency notice
------------------------------------------------------------------

- Nasdaq notified REVB on Aug 8, 2023 of noncompliance with minimum $1.00 bid price rule for 30 consecutive business days.
- Company has a 180-day grace period until Feb 5, 2024 to regain compliance; common stock must close at $1.00+ for 10 consecutive days.
- If not cured, may be eligible for an additional 180-day extension pending meeting other listing standards and reverse stock split if needed.
- Noncompliance has no immediate impact on trading; stock continues listed on Nasdaq Capital Market.
- Company is evaluating options to maintain listing including potential reverse stock split.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1810560/000095017023041840/0000950170-23-041840-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1810560/000095017023041840/revb-20230808.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-041840

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer